vos-headline-type-email-header-062620

ISSUE HIGHLIGHTS

Thumbnail_Montage_Q3
Events & Education

Featured Video: Voices From the Conference: Credibility of RWE + Leveraging Cures

Virtual ISPOR Europe 2020
Events & Education

The Digital Endpoints Ecosystem and Protocols (DEEP) Initiative

Virtual ISPOR Europe 2020
Events & Education

Novel Methods for Modeling Treatment Sequencing

W9 Contact Tracing_Figure 1_344x300
Events & Education

Contact Tracing Policies for SARS-CoV-2: Lessons Learned to Inform Decision Makers

Fig1 W11_cropped map_344x300
Events & Education

The COVID-19 Trial Tracker: A Framework to Provide Real-Time Updates on Emerging Evidence

Virtual ISPOR Europe 2020
Events & Education

Preventing the Breakdown of the Healthcare System: How to Use the SIR Model to Allocate Medical Resources Better

W6_Surrogate Endpoints _Figure 1_344x300
Events & Education

The Use of Surrogate Endpoints in Regulatory and HTA Submissions

Thumbnail_Montage_Q2
Events & Education

Featured Video: Voices From the Conference: Value of Innovation + Scientific Evidence of COVID-19

Virtual ISPOR Europe 2020
Events & Education

Could International Reference Pricing “Go Viral” After COVID-19?

Virtual ISPOR Europe 2020
Events & Education

Hot off the Production Line! The New Generalized Risk Adjusted Cost-Effectiveness (GRACE) Model

Plenary 3_Figure 1_344x300
Events & Education

Much Ado About Little: Dealing With Limited RCT Evidence for Early HTA and Reimbursement Decisions

Virtual ISPOR Europe 2020
Events & Education

How Can We Balance Quantifying the Broad Societal Benefits of Vaccines with Paying for Them?

IP11_Multinational HTA_Figure 2 cropped_344x300
Events & Education

Multinational HTA: Does IT Really Benefit Public Health and Promote Access to Innovation?

Virtual ISPOR Europe 2020
Events & Education

Bridging the Gap: Pathways for Regulatory and HTA of Histology Independent Therapies

VOS Spotlight Thumbnails344x350_InterviewRichardCharter
Events & Education

Featured Video: Full-Length Video Interview With Richard Charter (Alira Health)

IP8_ Integrating Patient Preference in HTA_Figure 2_344x300
Events & Education

Integrating Patient Preference Into HTA

Virtual ISPOR Europe 2020
Events & Education

Patient and Public Involvement in Healthcare Decision Making: Are We Maximizing Opportunities?

Women in HEOR_Figure 2_344x300
Events & Education

Women in HEOR: Adapting to the New Normal

Virtual ISPOR Europe 2020
Events & Education

How Should Pharmaceutical Companies and Patients Share the Value Generated by New Medicines?

W2_ Guidelines for Economic Evaluation_Figure 1a_344x300
Events & Education

How Guidelines Keep Up With Emerging Technologies and Developing Methods

Virtual ISPOR Europe 2020
Events & Education

Is Europe Ready to Value and Reimburse the Next Medical Frontier?

VOS Spotlight Thumbnails344x300_Tuesday
Events & Education

Featured Video: The Link Between ACPIs and Value-Based Healthcare

Virtual ISPOR Europe 2020
Events & Education

Accounting for Caregiver Burden in HEOR

VOS Spotlight Thumbnails (2)
Events & Education

Featured Video: Welcome to ISPOR Europe 2020

Virtual ISPOR Europe 2020
Events & Education

Allocating Resources During a Pandemic: To HTA or Not to HTA?

IP3_Cures_Figure 2_344x300
Events & Education

The Meaning and Value of “Cure” Beyond Statistical Survival Models

Virtual ISPOR Europe 2020
Events & Education

International Collaboration in Response to the Global COVID-19 Pandemic

Plenary image_344x300
Events & Education

“New Deal” for Healthcare Systems: Mission Inspirational, Impossible, or Inevitable?

Virtual ISPOR Europe 2020
Events & Education

Will COVID-19 Accelerate the Adoption of Digital Health Technologies?

Fig 1_IP1_344x300
Events & Education

Is It Time to Find Greater Efficiencies in HTA for Rare Diseases and Cell and Gene Therapies?

COLUMNS

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×